Evolus, Inc. financial data

Symbol
EOLS on Nasdaq
Industry
Pharmaceutical Preparations
Location
520 Newport Center Drive, Suite 1200, Newport Beach, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 272 % +29%
Quick Ratio 24.2 % -46.3%
Debt-to-equity 3.73K %
Return On Equity -966 % -103%
Return On Assets -25.3 % +32.4%
Operating Margin -16.4 % +40.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 63.3M shares +10.8%
Common Stock, Shares, Outstanding 63.3M shares +10.8%
Entity Public Float 405M USD -4.42%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 63.1M shares +10.7%
Weighted Average Number of Shares Outstanding, Diluted 63.1M shares +10.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 248M USD +34.4%
Research and Development Expense 1.69M USD -17.8%
Costs and Expenses 289M USD +22.5%
Operating Income (Loss) -40.7M USD +20.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -55.1M USD +12.3%
Income Tax Expense (Benefit) 330K USD +160%
Net Income (Loss) Attributable to Parent -55.5M USD +12%
Earnings Per Share, Basic -0.9 USD/shares +19.6%
Earnings Per Share, Diluted -0.9 USD/shares +19.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 85M USD +120%
Accounts Receivable, after Allowance for Credit Loss, Current 44.6M USD +46.5%
Inventory, Net 14.9M USD -15.5%
Other Assets, Current 2.39M USD +52.5%
Assets, Current 150M USD +63.4%
Property, Plant and Equipment, Net 2.31M USD +8.64%
Operating Lease, Right-of-Use Asset 8.28M USD +40.2%
Intangible Assets, Net (Excluding Goodwill) 46.6M USD +0.18%
Goodwill 21.2M USD 0%
Other Assets, Noncurrent 858K USD +286%
Assets 230M USD +36.7%
Accounts Payable, Current 13.8M USD +17.7%
Employee-related Liabilities, Current 10.9M USD +15.2%
Accrued Liabilities, Current 34.9M USD +30.8%
Contract with Customer, Liability, Current 13.2M USD +50.7%
Liabilities, Current 60.8M USD +25.3%
Deferred Income Tax Liabilities, Net 29K USD +31.8%
Operating Lease, Liability, Noncurrent 7.07M USD +41.8%
Liabilities 224M USD +19.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -689K USD -13.7%
Retained Earnings (Accumulated Deficit) -603M USD -10.1%
Stockholders' Equity Attributable to Parent 5.89M USD
Liabilities and Equity 230M USD +36.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.6M USD +48.4%
Net Cash Provided by (Used in) Financing Activities 45.7M USD
Net Cash Provided by (Used in) Investing Activities -797K USD -56%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 63.3M shares +10.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 34.1M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 85M USD +120%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.42M USD
Deferred Tax Assets, Valuation Allowance 116M USD +11.9%
Operating Lease, Liability 8.67M USD +36.6%
Payments to Acquire Property, Plant, and Equipment 256K USD +12.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -55.5M USD +12.2%
Lessee, Operating Lease, Liability, to be Paid 11.3M USD +25.5%
Operating Lease, Liability, Current 1.6M USD +17.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.14M USD +103%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.71M USD +24.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure -9.09%
Deferred Income Tax Expense (Benefit) 5K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.64M USD -0.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.21M USD +52.4%
Deferred Tax Assets, Operating Loss Carryforwards 83.3M USD +3.43%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 2.92M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.29M USD +52.5%
Additional Paid in Capital 609M USD +15.3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 4.18M USD +7.2%
Depreciation, Depletion and Amortization 5.3M USD +10.6%
Deferred Tax Assets, Net of Valuation Allowance 9.16M USD -25.8%
Share-based Payment Arrangement, Expense 20.5M USD +41.5%
Interest Expense 15.7M USD +60%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%